Department of Anaesthesiology and Pain Medicine, Seoul National University Hospital, Seoul, Korea.
Cheoncheon Public Health Subcentre, Jangsu Health Centre and County Hospital, Jangsu, Jeollabuk-do, Korea.
Anaesthesia. 2017 Feb;72(2):204-213. doi: 10.1111/anae.13642. Epub 2016 Sep 26.
The infusion of fluids to patients may affect tissue microcirculation and the endothelial glycocalyx. However, the effects of hydroxyethyl starch and crystalloid on endothelial glycocalyx degradation and microvascular reactivity have not been evaluated in detail. We hypothesised that hydroxyethyl starch may cause less endothelial glycocalyx degradation and better microvascular reactivity than that caused by crystalloid. We randomly allocated 120 patients undergoing off-pump coronary artery bypass graft surgery to receive up to 20 ml.kg of either hydroxyethyl starch 670/0.75 or crystalloid for intra-operative fluid resuscitation. Crystalloid was then infused to meet ongoing fluid requirements. During the peri-operative period, vascular occlusion tests were performed to assess microvascular reactivity, and serum syndecan-1 was measured as an index of endothelial glycocalyx degradation. The median (IQR [range]) fluid infused during surgery was significantly less in the hydroxyethyl starch group than the crystalloid group; 2800 (2150-3550 [1400-7300]) vs. 3925 (3100-4725 [1900-6700]) ml, respectively, p < 0.001. Vascular occlusion test parameters, including tissue oxygen saturation, occlusion and recovery slope did not differ significantly between the groups. Peri-operative changes in syndecan-1 were not significantly different between the groups. We conclude that, in patients undergoing off-pump coronary artery bypass graft surgery, compared with crystalloid, the use of hydroxyethyl starch 670/0.75 did not result in significant differences in microvascular reactivity or endothelial glycocalyx degradation.
给患者输注液体可能会影响组织微循环和内皮糖萼。然而,羟乙基淀粉和晶体液对内皮糖萼降解和微血管反应性的影响尚未详细评估。我们假设羟乙基淀粉引起的内皮糖萼降解比晶体液少,微血管反应性更好。我们将 120 名接受非心脏冠状动脉旁路移植术的患者随机分配,接受高达 20 ml/kg 的羟乙基淀粉 670/0.75 或晶体液用于术中液体复苏。然后输注晶体液以满足持续的液体需求。在围手术期,进行血管闭塞试验以评估微血管反应性,并测量血清 syndecan-1 作为内皮糖萼降解的指标。羟乙基淀粉组术中输注的液体中位数(IQR[范围])明显少于晶体液组;分别为 2800(2150-3550[1400-7300])与 3925(3100-4725[1900-6700])ml,p<0.001。血管闭塞试验参数,包括组织氧饱和度、闭塞和恢复斜率,两组之间无显著差异。两组之间围手术期 syndecan-1 的变化无显著差异。我们的结论是,与晶体液相比,在接受非心脏冠状动脉旁路移植术的患者中,使用羟乙基淀粉 670/0.75 不会导致微血管反应性或内皮糖萼降解的显著差异。